Clinical Trial Update: Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating repeated superselective intraarterial infusion of bevacizumab with temozolomide and radiation versus temozolomide and radiatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Northwell Health | Conditions: Glioblastoma, Glioblastoma Multiforme | Phase 3 | Status: RECRUITING